Evolv Technologies ($EVLV) Investor Settlement

The parties have reached an agreement to settle the case, but the terms are still being finalized. You can submit your application now, and it will be processed once claims filing opens.

D. Massachusetts

Court

1:24-cv-10761

Case number

06/28/2021

Class period Start

10/25/2024

Class period End

Evolv Technologies ($EVLV) has reached a settlement with investors to resolve claims that it misled the market about the reliability of its weapons detection technology and improperly recognized revenue tied to undisclosed contract terms.

Outline:

In 2021, Evolv went public while promoting its AI-based weapons detection technology as highly effective. However, soon, the company was accused of overstating the system’s capabilities and improperly recognizing revenue. As regulatory scrutiny increased, Evolv restated financials, and $EVLV fell 39%, prompting an investor lawsuit.

Timeline:
July 2021: Evolv went public through a SPAC merger with NewHold Investment Corp.
October 12, 2023: Evolv revealed FTC investigation into deceptive marketing; shares dropped 13.3%.
February 19, 2024: SEC investigation disclosed; $EVLV fell 15.7%.
October 25, 2024: Evolv announced financial restatements due to improper revenue; stock plunged 39.75%.
October–November 2024: CEO Peter George was terminated following an internal review, and the CFO resigned after admitting oversight failures.
September 2025: A settlement was reached between Evolv and its investors.
Background:

Evolv went public in July 2021 through a SPAC merger, promoting its “Evolv Express” AI weapons detection system as a major innovation. The company claimed independent validation and strong effectiveness.
However, it was later revealed that those claims were false. In March 2024, a BBC exposé showed that the technology failed to detect common weapons, contradicting Evolv’s marketing.

Regulatory pressure mounted in late 2023 and early 2024. On October 12, 2023, Evolv disclosed an FTC investigation, followed by an SEC investigation announced on February 19, 2024. Around the same time, internal findings showed the company had improperly recorded revenue from contracts lacking proper approvals or binding terms.

On October 25, 2024, Evolv issued adjustments to its financial statements for multiple prior quarters, causing shares to plunge 39.75%.

Following these revelations, CEO Peter George was terminated, and the CFO resigned. Investors filed a lawsuit seeking recovery for the losses caused by these issues.

In 2025, a settlement was reached between Evolv and its investors.

What Can Investors Expect Now?

Evolv Technologies ($EVLV) has reached a settlement with investors to resolve claims that it misled the market about the reliability of its weapons detection technology and improperly recognized revenue tied to undisclosed contract terms.

If you were damaged due to this situation, you can file for a payout and get your share of the settlement. You can check if you are eligible and other details in the FAQ section below.

Case Type

US Securities Class Action

Case Status

Tentative Settlement

Alleged Offence

Mismanagement,

Misleading Statements,

Omissions

Suspected Party

Directors,

Management

Security Type

Stocks

Trade Direction

Long

Filing date

03/25/2024

Lead Plaintiff Deadline

05/25/2024

Plaintiffs

Gerald Raby

Attorneys

The Rosen Law Firm, P.A.

Defendants

Peter George, Mario Ramos, Mark Donohue, Kevin Charlton, Adam Deutsch

Trades matching type

FIFO

Frequently Asked Questions

Trusted by industry leaders

Endorsed by top professionals who trust our innovative solutions to drive impactful results.